Lenalidomide induced Akt upregulation was seen in both central memory and effector memory XBP1-CTL subsets, but not the terminal effector subset, in response to breast cancer (MDA-MB231, Figure 8B) and colon cancer (SW480, Figure 8C) cells. Here, AKT1 is linked to malignant colon neoplasm.